Unity Biotechnology shares almost hit $10 a couple of weeks ago, and since peaking they have shed almost a third of their value, finding support in the process. I have been a long-term investor in UBX for around four months now, and I bought additional shares on Friday because of this stellar entry point. UBX has been very reliable in past months with this support line, and I think shares could easily push up to $12 this month. For the short term I am targeting around $9.90. Good Luck!
